Skip to Content

CNBX Pharmaceuticals Inc CNBX Stock Quote

| Rating as of


Last close prices updated as of Feb 08, 2023, 3:51 PM EST | USD
  • Last Close 0.11
  • Sector Healthcare
  • Industry Biotechnology
  • Investment Style
  • Day Range 0.11  –  0.17
  • Year Range 0.11  –  12.00
  • Market Cap 138,371.9700
  • Volume / Avg 223,040.0 /  17,846.1
  • Price / Sales 7,961.35
  • Price / Book 20.39
  • Forward Div Yield
  • Trailing Div Yield

Morningstar‘s Stock Analysis CNBX

Currency in
Is it the right time to buy or sell?
Is it the right time to buy or sell?

1-Star Price


5-Star Price


Economic Moat


About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Unlock Our Full Analysis With Morningstar Investor

Key Statistics CNBX

Company Profile CNBX

Business Description

CNBX Pharmaceuticals Inc is a biotechnology company. It develops pharmaceuticals focusing on cancer research utilizing HTS technology and personalized bioinformatics tools. The company's main focus is the development of cannabinoid therapies and other technologies for the treatment of cancer, mainly cancers of the gastrointestinal tract, skin, breast, and prostate. Other areas of the research include Alzheimer’s disease, mental health conditions, and auto-immune diseases The firm's main product is the RCC-33, an oral capsule for the treatment of colorectal cancer. The company tools include delivery systems, personalized medicine diagnostics, and therapies based on Cannabinoid compounds.

No. 3 Bethesda Metro Center, Suite 700
Bethesda, MD, 20814
Industry Biotechnology
Employees 5

FAQs for CNBX Pharmaceuticals Inc Stock

No. CNBX does not currently have a forward dividend yield.
Dividend yield allows investors, particularly those interested in dividend-paying stocks, to compare the relationship between a stock’s price and how it rewards stockholders through dividends. The formula for calculating dividend yield is to divide the annual dividend paid per share by the stock price.

Learn more about dividend yield.

CNBX’s market cap is 138,371.97.
Market capitalization is calculated by taking a company’s share price and multiplying it by the total number of shares. It’s often used to measure a company’s size. In the Morningstar Style Box, large-cap names account for the largest 70% of U.S. stocks, mid-cap names account for the largest 70–90%, and small-cap names are the remaining 10% of companies.

Learn more about market capitalization.

CNBX’s beta can be found in Trading Information at the top of this page.
A stock’s beta measures how closely tied its price movements have been to the performance of the overall market.

Compare CNBX’s historical performance against its industry peers and the overall market.